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The mechanism by which the antigen-specific immune system distinguishes between
foreign antigens (toward which it mounts an immune response) and self-antigens (of
which it is tolerant) is not completely understood. Studies using "superantigens" and
transgenic mice have allowed investigations into some of the mechanisms of clonal
deletion, anergy, and peripheral tolerance. In the present report, we have attempted to
develop a new model system to investigate the possible mechanism(s) eripheral
tolerance to allografts. In this system, skin grafts from C57BL/6J (B6; H-2u mice are
grafted onto T- and B-lymphocyte-deficient C.B-17-scid/scid (H-2a; hereafter referred to
as scid) mice. Because of their lack of functional lymphocytes, the scid mice readily
accept the allogeneic skin grafts. After the allografts healed, the scid mice were
reconstituted with T-cell-deficient fetal liver from coisogeneic C.B-17-/-/ mice or bone
marrow from weanling congenitally athymic BALB/c-nu/nu (H-2a; hereafter referred to
as nude) mice. Upon immunological reconstitution, the scid mice reiected the established
B6 skin allografts, suggesting that an immune system developing in the presence of an
intact peripheral skin allograft fails to develop tolerance to the peripheral allograft. This
model system may be useful for the study of the mechanisms required for the induction
of peripheral tolerance.
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INTRODUCTION
Over the past few years, two major technical
advances have allowed the issue of self-tolerance
to be examined in greater detail. First has been
the observation that significant percentages of T
lymphocytes are responsive to a group of "super-
antigens" including those encoded by the major
histocompatibility complex (MHC) I-E genes,
minor lymphocyte stimulatory (Mls) loci, and
certain bacterial toxins (for reviews, see Webb
and Sprent, 1989; Blackman et al., 1990; Kisielow
et al., 1991). This has had a major impact on the
understanding of tolerance to antigens expressed
in the thymus by cells of the lymphoid/bone
marrow lineage and suggests that there are at
least two distinct mechanisms, clonal deletion
*Corresponding author.
and clonal anergy, by which T lymphocytes with
the potential to be autoaggressive are inacti-
vated. Second has been the development of trans-
genic mice useful in the study of the establish-
ment of tolerance to immunogens that are
expressed in a tissue-specific manner, particu-
larly by solid tissues of nonlymphoid nature
(MacDonald, 1989; Allison et al., 1990; Hanahan,
1990; Lo, 1990; Lo et al., 1991). Observations in
transgenic mice have supported the concept that
this form of antigen presentation by non-pro-
fessional antigen-presenting cells (APC) results
in clonal anergy and the induction of peripheral
tolerance.
In the present study, we sought to develop a
strategy to examine the development of tolerance
to extrathymically expressed alloantigens by
solid tissues, where more than one cell type
might express the alloantigen. Ideally, we
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TABLE
Immunological Reconstitution of scid Mice with C.B-17-7t/7 Fetal Liver
Group Spleen Thymus
Cell number CD3 sIg Cell number CD3 sIg
(x10-6) (x10-6)
A 54.5 60.1 14.1 81.5 37.8 0.7
(n=2)
B 37.2+8.0 32.9+13.0 21.6+13.3 33.2+14.3 28.0+10.1 3.5+2.8
(n=5)
C 5.6+4.4 1.2+1.0 1.5+1.2 < N.D. N.D.
(n=5)
D 9.1+6.1 28.5+8.0 15.6+4.9 5.6+7.6 19.7+3.9 3.8+0.9
(n=4)
BALB/c 81.0+31.9 39.1+11.7 46.2+11.5 44.7+16.3 27.5+6.5 1.4+0.5
(n=5)
aA total of five scid mice in group A with established B6 allografts injected i.v. with 10106 C.B.-17-/ day-16 gestation fetal liver cells 4 weeks after skin grafting.
Two phenotyped for evaluation of immunological reconstitution at necropsy. The scid mice in group B injected with C.B-17-/t fetal liver weeks prior to B6
skin grafting. The scid mice in group C grafted with B6 skin allografts with further manipulation. The B6 skin grafted scid mice in group D injected with 10x106
C.B-17-7t/ adult spleen cells 4 weeks after skin grafting. The BALB/c controls 12-16 weeks of age. The relative proportion of CD3 and surface-immunoglobulin-
positive (sIg/) lymphocytes determined at necropsy by flow cytometry.
wanted to establish an experimental model that
would (1) permit manipulation of the immune
system during its development, (2) allow induc-
tion of tolerance to various target tissues and
organs, and (3) allow the utilization of the unique
transgenic and mutant mice that are now avail-
able. Our basic experimental design exploits the
C.B-17-scid/scid (H-2d) mutant mouse that lacks
functional T and B lymphocytes. Because such a
mouse readily accepts allografts, we could trans-
plant allogeneic tissues, allow them to heal in
place, and then immunologically reconstitute the
host. Our results indicate that an immune system
developing in the presence of foreign skin allog-
rafts expressing both allo-class I and-class II
MHC antigens is sensitized to and rejects the skin
allografts. This basic model system should allow
the dissection of the developing immune system
and the target organs and tissues to allow deter-
mination of the parameters that may be import-
ant in the induction of peripheral tolerance.
RESULTS
In the first series of experiments, we transplanted
full-thickness skin grafts from a C57BL/6J mouse
(H-2b) on the flanks of scid mice. These allografts
were readily accepted and allowed to heal. Four
weeks after skin grafting, we injected 10x106 C.B-
17-7z/7t fetal liver cells into a group of mice with
established B6 skin allografts (group A) and into
ungrafted scid mice that received B6 skin allo-
grafts 2 weeks after reconstitution (group B). A
group of unreconstituted scid mice that were
grafted with B6 skin were not manipulated
further (Group C) and a group of scid mice with
established B6 skin allografts received 10x106
C.B-17-7t/7a spleen cells (group D) 4 weeks after
skin grafting. Skin-graft survival was followed in
all four groups. As expected, mice in groups A, B,
and D were immunologically reconstituted, and
developed both T (CD3/) and B (sIg/) lympho-
cytes (Table 1). In contrast, unreconstituted scid
mice with established B6 skin allografts (group
C) had no detectable T or B lymphocytes.
The B6 skin grafted onto unreconstituted scid
mice persisted until the time of necropsy (5/5)
(Table 2). Skin grafts placed on group B mice (i.e.,
scid mice that had been immunologically recon-
stituted before allografts were placed) were
TABLE 2
Median survival Times (MST) of Allogeneic C57BL/6J
(H-2b) Skin Grafts on Immune Reconstituted C.B-17-scid/scid
(H-2d) Mice
Experiment Treatment MST
(days)
A 44, 53, 40, 55, 45
B <12
C >70
D <14
A 41, 43, 48, 43
B <14
C >70
aSee Tables and for details of experimental groups and II, respectively.
bThe median survival time determined by assessment of the time at which
50% of the graft rejected.
CGraft rejection occurred rapidly, within 1-4 days of the first signs of rejection. All
grafts in this group evidence 50% greater rejection within this time period.
aGrafts remained intact throughout the observation period until necropsy.PERIPHERAL TOLERANCE IN Scid MICE 47
TABLE 3
Immunological Reconstitution of scid Mice with BALB/c-nu/nu Bone Marrow.
Group Spleen Thymus
Cell number CD3 sIg Cell number CD3 sIg
(x10-6) (x10-6)
Aa 80.0 40.1 51.9 19.0+2.7 78.9+5.1 3.3+1.6
(n=4)
B 68.8 48.8 43.3 9.0 71.1 <1
(n=4)
C 5.4+3.3 1.2+1.8 1.7+1.8 <1 N.D. N.D.
(n=5)
aA total of four scid mice in group A with established B6 nude skin allografts and four scid mice in group B injected i.v. with 5X10 BALB/c-nu/nu bone cells;
group B mice received B6 nude skin allografts weeks later. The scid mice in group C received B6 nude skin grafts with further manipulation. Spleens pooled at
necropsy for analysis of cytotoxic T-cell activity and phenotypic analysis. The thymuses from the four mice in group A analyzed individually; the thymuses in group B
pooled for cell counts and phenotypic analysis. The relative proportion of each cell subset determined by flow cytometry in Table 1.
rejected within 12 days after engraftment (5/5).
Reconstitution of B6 allograft-bearing scid mice
with C.B-17-/7 adult spleen cells (group D)
resulted in graft rejection within 14 days (4/4). In
scid mice with established allografts that received
fetal liver (group A), grafts were rejected 47.4+6.3
days after reconstitution (5/5), suggesting a lack
of tolerance induction to the peripheral allo-
MHC antigens (Table 2).
Alternative explanations for the foregoing
results must also be considered. The B6 skin
grafts might contain passenger T lymphocytes,
because they came from an immunologically nor-
mal mouse. Thus, in reconstituted scid mice, a
mixed lymphocyte reaction might ensue within
the graft, with local release of lymphokines such
as interleukin-2. Essery et al. (1988) have shown
this can reverse the nonresponsiveness of toler-
ized T lymphocytes. Also, there is a formal possi-
bility that mature T lymphocytes with allo-
specific reactivity were contained within the
administered fetal liver cells. These preexisting T
lymphocytes could be responsible for the skin-
graft rejection, rather than T cells that developed
in the scid thymus. To address these possibilities,
we exploited available mutant mouse stocks to
confirm our initial observations.
C.B-17-scid-scid mice were again allografted,
this time using skin from B6-nude mice to reduce
the possibility of transfer of passenger T lympho-
cytes. Contralateral skin grafts from BALB/c-
nude mice were also placed on the scid mice. The
skin grafts were accepted by the scid mice, and
allowed to heal in place for 4 weeks. At this time,
bone marrow cells from weanling BALB/c-nude
mice were injected into B6 skin-grafted scid mice
(group A) and into ungrafted scid mice (group B).
Two weeks following the bone marrow injection,
TABLE 4
Anti-H-2 Cytotoxic T-Cell Precursor Activity in C57BL/6J
(H-2b) nude Skin Grafted, Immune Reconstituted
C.B-17-scid/scid (H-2d) Mice"
Group Target cell percent lysis
P815 EL-4
(H-2d) (H-2b)
A 0.3+0.5 20.6+1.4
B 0.9+1.2 28.9+1.6
aFour scid mice in group A with established B6 nude skin allografts received 5x106
BALB/c-nu/nu bone cells. Four scid mice in group B reconstituted
with 5X10 BALB/c-nu/nu bone cells and received B6 nude skin allografts 2
weeks later. Spleen cytotoxic T-cell precursor activity ot H-2 expressing EL-4 (skin-
graft donorMHC haplotype) and H-2 expressing P815 (syngeneic MHC haplotype)
chromium-51 labeled target cells determined 2-3 weeks after final graft
rejection (see Methods and Materials).
B6-nude and BALB/c-nude skin grafts were
placed on contralateral flanks of each of the mice
in group B. One group of skin-grafted scid mice
was not reconstituted (group C). Skin-graft sur-
vival was followed in all three groups. At nec-
ropsy, bone marrow reconstituted scid mice
(groups A and B) exhibited the development of
both T (CD3/) and B (sIg/) cells, whereas unre-
constituted scid mice (group C) had no detectable
T or B lymphocytes (Table 3).
As in the first experiment, the B6-nude skin
grafts on unreconstituted scid mice (group C)
were still intact at necropsy (5/5); reconstituted
and then grafted scid mice (group B) rejected the
B6-nude skin grafts within 14 days (4/4) (Table
3). The well-healed allogeneic B6-nude skin grafts
in group A scid mice were rejected 43.8+/-3.0
days after reconstitution with BALB/c-nude bone
marrow (4/4) (Table 3). The histocompatible
BALB/c-nude skin grafts remained intact in all
mice. Furthermore, spleen cells recovered from
reconstituted scid mice (groups A and B) demon-
strated high cytotoxic T-cell precursor activity to48 T.V. RAJAN, L.D. SHULTZ AND D.L. GREINER
the H-2
b allo-MHC in vitro (Table 4), again sug-
gesting a lack of tolerance to the peripherally
expressed skin allograft.
DISCUSSION
In the present study, we have demonstrated that
when T cells mature in the presence of a periph-
eral skin allograft, tolerance does not develop.
The rejection of the skin allograft does not appear
to be due to the transfer of preformed alloreac-
tive T cells, because bone marrow from athymic
nude donors developed into lymphocytes reactive
to the allo-MHC that were capable of graft rejec-
tion. However, it has been observed that nude
mice do develop T cells as they age, although
young nude mice are severely deficient in T cells
(Holub, 1989; Vaesseen et al., 1986). Thus,
although it cannot be formally excluded that
transferred preformed T cells in the nude bone
marrow inoculum contributed to the graft rejec-
tion, our use of young (4-6 weeks of age) nude
mice as bone marrow donors reduced this possi-
bility. In addition, the possible contribution of T
lymphocytes from the skin graft itself was
reduced by the use of skin from nude mice, and
further studies in our laboratories using scid mice
as skin-graft donors support this conclusion.
Of particular interest is the difference in our
results to that observed in many of the transgenic
experiments. Although many possible expla-
nations might explain our divergent results, at
least two likely possibilities readily emerge. In
the transgenic studies, when an alloantigen is
expressed in a strictly cell- and tissue-specific
manner, the immune system of the animal is tol-
erant (Hanahan et al., 1989; Lo, 1990; Miller et al.,
1990; Lo et al., 1991). In these mice, the transgene
is present in the genome, and might be expressed
at low levels in the thymus, resulting in intra-
thymic clonal deletion rather than induction of
peripheral tolerance. However, investigators
have used several sensitive assays including $1
protection and PCR to ensure that there is no
detectable expression of the transgene in the thy-
muses of the mice. Furthermore, Lo et al. (1991)
replaced the thymus and bone marrow with non-
transgenic tissues, absolutely precluding
endogenous thymic expression of the product of
the transgene.
A second difference is that expression of the
alloantigen in our model occurs in numerous cell
types and in several discrete tissues, including
the epidermis and dermis of the skin. It is poss-
ible that in our system, the alloreactive T cells
could be given a stimulatory second signal by
epidermal dendritic cells or Langerhans cells,
that is, professional APCs (for review, see Stein-
man, 1991; also see Schuler and Steinman, 1985;
Heufler et al., 1987). In contrast, in the transgenic
systems of peripheral tolerance, the expression of
the alloantigens is confined exclusively to that of
class II-negative, nonprofessional APC. The in
vitro tolerization model described by Schwartz et
al. (1990) proposes that exposure of T cells to
antigen in the absence of appropriate APCs
results in tolerance rather than activation. This
suggests that in transgenic mice, the antigen is
presented on nonprofessional APC, resulting in
the absence of an appropriate "second" signal.
Lack of professional APCs in an allograft
would then be predicted to result in tolerance
induction. It has been estimated that Langerhans
cells turn over in the skin in about 5 weeks
(Lacey and Davey, 1984). Therefore, in a prelimi-
nary experiment, we analyzed the effect of pro-
longed graft healing before immunological
reconstitution. A C.B-17-scid/scid mouse with an
intact C57BL/6-scid/scid skin graft was reconsti-
tuted 20 weeks later with BALB/c-nu/nu bone
marrow. This time period of graft survival
should have allowed Langerhans cells in the
graft to turn over prior to bone marrow reconsti-
tution. However, 8 weeks after reconstitution, the
graft was rejected. This preliminary experimental
result suggests that the presence (or absence) of
Langerhans cells in the skin grafts may not be the
sole crucial element in determining graft sur-
vival. This is consistent with the observations of
Streilein et al. (1979, 1982), who used skin and
cornea as grafts that differed in the presence or
absence of Langerhans cells, respectively. They
observed that corneal grafts were accepted by
MHC class II disparate hosts, whereas identical
donor-skin allografts were accepted only when
the graft was pretreated to eliminate Langerhans
cells. In contrast, both corneal and cutaneous
allografts were rejected in MHC class I disparate
combinations.
Our results are consistent with those of
Besedovsky et al. (1979). They observed that nude
mice rejected healed allografts when immuno-
logically reconstituted with syngeneic thymicPERIPHERAL TOLERANCE IN Scid MICE 49
implants. More recently, Gao et al. (1991)
observed a lack of tolerance induction in chim-
eras when newly maturing lymphocytes were
exposed to MHC class II alloantigens on "non-
professional" APCs.
Our model system, as described, now allows
some of the parameters that are necessary for
peripheral tolerance induction to be examined. In
ongoing studies, we are investigating the induc-
tion of peripheral tolerance to MHC class I and
class II deficient skin grafts and islet grafts, and
we are investigating the possible role of B lym-
phocytes in induction of peripheral tolerance to
allografts. We believe that this basic model sys-
tem now can be modified to investigate and to
individually dissect the effects that perturbations
in lymphocyte development and repertoire gen-
eration have on peripheral tolerance induction, to
determine how to induce tolerance to different
organ grafts and tissues, and to investigate how
alteration of the grafted tissues, either by genetic
(transgenic or knockout technology) or in vitro
pretreatment (e.g. to remove APC), effects the
induction of peripheral tolerance.
METHODS AND MATERIALS
Mice.
C.B-17-scid/scid mice, C.B-17- z/ z mice,
C57BL/6J-nu/nu mice, BALB/c-nu/nu mice, and
C57BL/6J- t/7z mice were obtained from the col-
ony maintained by LDS at the Jackson Labora-
tory (Bar Harbor, Maine). Because of the severe
immunodeficiency of the scid and nude mice, both
recipient and donor mice were maintained in
microisolator cages and provided autoclaved
food and water ad libitum. The scid mice were also
maintained prophylactically on a combination of
sulfamethoxazole and trimethoprim (Nelson et
al., 1991), which prevents them from succumbing
to Pneumocystis carinii pneumonia.
Antibodies.
The anti-CD3 monoclonal antibody (2Cll) was
the kind gift of Dr. J. Bluestone (Chicago,
Illinois), and was developed for immunofluor-
escence with mouse antihamster Ig-FITC. Surface
immunoglobulin-positive (B) cells were detected
with an FITC-conjugated goat antimouse IgG
(heavy- and light-chain-specific). The percent
positive cells were determined by flow cytometry
as previously described (Nelson et al., 1991).
Cell Suspensions.
Bone marrow cell suspensions were obtained by
flushing the tibia and femur with cold medium
(HEPES buffered RPMI 1640). Fetal liver was
recovered from fetuses at day 17-19 of ges-
tational development. Thymus, spleen, and fetal
liver-cell suspensions were prepared by gently
pressing the tissues through a 50-mesh cell sieve
followed by washing in cold medium. For flow
cytometry analysis, red blood cells were removed
by hypotonic lysis using 0.168 molar NH4CL. Cell
viability was determined by exclusion of 0.1%
trypan blue and was greater than 95% in all
cases.
Skin Grafting.
Skin graft donors were shaved, and approxi-
mately 2x2-cm full-thickness skin grafts were
prepared and grafted onto the flanks of the scid
mice (see text for details of specific donor and
recipient groups). Skin-graft rejection was evalu-
ated daily and the end point was defined as the
day when 50% of the skin graft detached from
the graft bed (Medawar, 1944; Billingham and
Medawar, 1951; Klein, 1975).
Adoptive Transfer.
Single-cell suspensions of fetal liver, bone mar-
row, or spleen were suspended at a concentration
of 20x106/ml and 0.5 ml was injected i.v. into the
tail vein of unirradiated scid mice.
Cytotoxic T-Cell Precursor Assay.
This assay was performed as previously
described (Woan et al., 1981). Briefly, spleen cells
were recovered from immune reconstituted C.B-
17-scid/scid mice. Sterile single-cell suspensions
were prepared, and 3.2x105 cells were incubated
with 2x105 2000-rad irradiated C57BL/6J spleen
cells in individual wells of a 96-well U-bottom
microtiter plate in the presence of 6 units of
exogenous IL-2 for 7 days. Following sensitiz-
ation, 5x104 51Cr-labeled EL-4 (H-2b) or P815 (H-
2d) target cells were added to each well, and incu-50 T.V. RAJAN, L.D. SHULTZ AND D.L. GREINER
bated for an additional 4 hours. The amount of
killing, that is, the amount of released 51Cr, was
determined by spinning the plates at 250 g for
5 min, harvesting the supernatant, and determin-
ing the counts in the recovered supernatant by
gamma counting. The specific lysis presented is
the mean+standard deviation of quadruplicate
wells and was calculated as previously described
(Woan et al., 1981).
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